Overview:
Among drug delivery devices, prefilled syringes represent one of the fastest growing primary packaging formats, which are also designed for dose administration. In fact, over the past ten years, there has been an evident increase in the development of parenteral drugs (especially with the introduction of several classes of biologics), which has resulted in an increased consumption of prefilled syringes, by approximately three fold. The sustained preference for such products can be attributed to the fact that prefilled syringes are safe and easy-to-use, and current variants are designed with provisions to reduce dosing errors, the risk of occlusions, extravasation and phlebitis. Owing to the aforementioned benefits, several injectable drugs (such as Humira®, Enbrel®, Avastin®, PREVNAR 13®, ALPROLIX® and Benefix®), diluents and other products requiring parenteral administration, are packaged in prefilled syringes. In fact, over the past seven years, around 90 drugs have been approved in combination with prefilled syringes across different geographies, including the North America, Europe and Asia-Pacific. Moreover, several clinical-stage drugs are being evaluated in combination with prefilled syringes, across different phases of development.
The filling of sterile drugs into prefilled syringes (and other primary drug containers) is considered to be one of the most crucial steps in the pharmaceutical production process. Proper fill / finish operations, carried out under aseptic conditions, is a necessity for not only maintaining pharmacological efficacy and quality, but also ensuring end user safety. The prefilled syringe filling operation is considered complex as it requires close monitoring of both the syringe fill volume as well as the headspace between the liquid in the syringe and the bottom of the plunger. Additionally, the rise in complexity of small molecule APIs and the increasing diversity of biologic drugs have also contributed towards the demand of advanced aseptic fill / finish operations. A number of small-sized companies and some large companies have outsourced their fill / finish operations to contract service providers. According to the 10th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production, biomanufacturers have been shown to outsource over 30% of their fill / finish operations. With the increase in the demand for prefilled syringes, along with the growing complexity of fill / finish processes, the outsourcing of these operations is likely to increase further in the future. Currently, over 100 companies are actively providing fill / finish services for prefilled syringes. In order to cope up with the current and future market demand, service providers are actively investing in expanding their existing infrastructure and capabilities; companies are also expanding their client reach through service agreements in the past few years. Given that around 55% of drug candidates in the global R&D pipeline are injectables, the opportunities for prefilled syringe developers / manufacturers and affiliated service providers is anticipated to continue to grow over the next decade. In addition, owing to the recent COVID-19 pandemic, an increase in the development initiatives for the vaccines is likely to be witnessed in the near future. This is expected to significantly raise the demand for prefilled syringes, providing an additional impetus to the overall fill / finish services market.
The 'Prefilled Syringe Fill / Finish Service Providers, 2020-2030' report features an extensive study of the current market landscape and future opportunities for contract service providers offering fill finish services for prefilled syringes.
TABLE OF CONTENTS
1. PREFACE
- 1.1. Scope of the Report
- 1.2. Research Methodology
- 1.3. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
- 3.1. Chapter Overview
- 3.2. Introduction to Prefilled Syringes
- 3.2.1. Advantages of Prefilled Syringes
- 3.2.1.1. Benefits to Healthcare Professionals and End Users
- 3.2.1.2. Benefits to Manufacturers
- 3.2.2. Classification of Prefilled Syringes
- 3.2.3. Manufacturing of Prefilled Syringes
- 3.3. Need for Outsourcing Fill / Finish Operations of Sterile Injectables
- 3.4. Factors Contributing to the Growth of Prefilled Syringe Fill / Finish Market
- 3.5. Fill / Finish of Prefilled Syringes
- 3.5.1. Key Steps in Fill / Finish Operations of Prefilled Syringes
- 3.5.2. Filling and Stoppering Methods
- 3.5.3. Syringe Filling Technologies
- 3.6. Basic Guidelines for Selecting a Fill / Finish Service Provider
- 3.7. Advantages of Outsourcing Fill / Finish Services
- 3.8. Risks and Challenges of Outsourcing Fill / Finish Operations
4. MARKET LANDSCAPE
- 4.1. Chapter Overview
- 4.2. Prefilled Syringe Fill / Finish Service Providers: Overall Market Landscape
- 4.2.1. Analysis by Year of Establishment
- 4.2.2. Analysis by Company Size
- 4.2.3. Analysis by Scale of Operation
- 4.2.4. Analysis by Location of Headquarters
- 4.2.5. Analysis by Location of Fill / Finish Facilities
- 4.2.6. Analysis by Company Size and Type of Drug Molecule
- 4.2.7. Analysis by Syringe Barrel Material
- 4.2.8. Analysis by Syringe Fill Volume
- 4.2.9. Analysis by Additional Services Offered
- 4.2.10. Grid Representation: Analysis by Year of Establishment, Company Size and Type of Drug Molecule
- 4.2.11. Logo Landscape: Analysis by Company Size and Type of Drug Molecule
- 4.2.5.1. World Map Representation: Analysis by Scale of operation and Location of Fill / Finish Facility
5. PREFILLED SYRINGE FILL / FINISH SERVICE PROVIDERS IN NORTH AMERICA: COMPANY PROFILES
- 5.1. Chapter Overview
- 5.2. Ajinomoto Bio-Pharma Services
- 5.2.1. Company Overview
- 5.2.2. Recent Developments and Future Outlook
- 5.3. AMRI
- 5.3.1. Company Overview
- 5.3.2. Recent Developments and Future Outlook
- 5.4. BioPharma Solutions
- 5.4.1. Company Overview
- 5.4.2. Recent Developments and Future Outlook
- 5.5. Emergent BioSolutions
- 5.5.1. Company Overview
- 5.5.2. Recent Developments and Future Outlook
- 5.6. Patheon
- 5.6.1. Company Overview
- 5.6.2. Recent Developments and Future Outlook
- 5.7. PiSA Farmacéutica
- 5.7.1. Company Overview
- 5.7.2. Recent Developments and Future Outlook
6. PREFILLED SYRINGE FILL / FINISH SERVICE PROVIDERS IN EUROPE: COMPANY PROFILES
- 6.1. Chapter Overview
- 6.2. Consort Medical
- 6.2.1. Company Overview
- 6.2.2. Recent Developments and Future Outlook
- 6.3. EVER Pharma
- 6.3.1. Company Overview
- 6.3.2. Recent Developments and Future Outlook
- 6.4. GlaxoSmithKline
- 6.4.1. Company Overview
- 6.4.2. Recent Developments and Future Outlook
- 6.5. IDT Biologika
- 6.5.1. Company Overview
- 6.5.2. Recent Developments and Future Outlook
- 6.6. Rentschler Biopharma
- 6.6.1. Company Overview
- 6.6.2. Recent Developments and Future Outlook
- 6.7. Siegfried
- 6.7.1. Company Overview
- 6.7.2. Recent Developments and Future Outlook
- 6.8. Vetter Pharma
- 6.8.1. Company Overview
- 6.8.2. Recent Developments and Future Outlook
7. PREFILLED SYRINGE FILL / FINISH SERVICE PROVIDERS IN ASIA-PACIFIC: COMPANY PROFILES
- 7.1. Chapter Overview
- 7.2. Biocon
- 7.2.1. Company Overview
- 7.2.2. Recent Developments and Future Outlook
- 7.2. Intas Pharmaceuticals
- 7.2.1. Company Overview
- 7.2.2. Recent Developments and Future Outlook
- 7.3. Kemwell Biopharma
- 7.3.1. Company Overview
- 7.3.2. Recent Developments and Future Outlook
- 7.4. Square Pharmaceuticals
- 7.4.1. Company Overview
- 7.4.2. Recent Developments and Future Outlook
- 7.5. USV
- 7.5.1. Company Overview
- 7.5.2. Recent Developments and Future Outlook
8. PREFILLED SYRINGE FILL / FINISH SERVICE PROVIDERS: RECENT DEVELOPMENTS
- 8.1. Chapter Overview
- 8.2. Partnership Models
- 8.3 List of Partnerships and Collaborations
- 8.3.1. Analysis by Year of Partnership
- 8.3.2. Analysis by Type of Partnership
- 8.3.3. Analysis by Scale of Operation (Deal Specific)
- 8.3.5. Analysis by Additional Services Offered (Deal Specific)
- 8.3.6. Most Active Players: Analysis by Number of Partnerships
- 8.4. List of Expansions
- 8.4.1. Analysis by Year of Expansion
- 8.4.2. Analysis by Type of Expansion
- 8.4.3. Analysis by Expanded Scale of Operation
- 8.4.4. Analysis by Location of Expansion Project
- 8.4.5. Analysis by Type of Drug Molecule Involved
- 8.4.6. Analysis by Additional Services Offered (Expansion Specific)
9. CAPACITY ANALYSIS
- 9.1. Chapter Overview
- 9.2. Assumptions and Methodology
- 9.3. Global, Prefilled Syringe Fill / Finish Capacity (by Number of Units)
- 9.3.1. Analysis by Company Size (Manufacturer)
- 9.3.2. Analysis by Scale of Operation
- 9.3.3. Analysis by Location of Headquarters
- 9.3.4. Analysis by Location of Fill / Finish Facilities
- 9.3.5. Analysis by Type of Drug Molecule
- 9.4. Global, Prefilled Syringe Fill / Finish Capacity (by Volume)
- 9.4.1. Analysis by Company Size (Manufacturer)
- 9.4.2. Analysis by Scale of Operation
- 9.4.3. Analysis by Location of Headquarters
- 9.4.4. Analysis by Location of Fill / Finish Facilities
- 9.4.5. Analysis by Type of Drug Molecule
10. DEMAND ANALYSIS
- 10.1. Chapter Overview
- 10.2. Assumptions and Methodology
- 10.3. Global Demand for Prefilled Syringe Fill / Finish Services
- 10.3.1. Analysis by Geography
- 10.3.2. Analysis by Type of Drug Molecule
- 10.3.3. Analysis by Therapeutic Area
- 10.3.4. Analysis by Syringe Barrel Material
- 10.3.5. Analysis by Number of Barrel Chambers
- 10.4. Analysis of Demand and Supply Dynamics
11. GEOGRAPHICAL ASSESSMENT OF DEMAND AND SUPPLY
- 11.1. Chapter Overview
- 11.2. Demand and Supply Assessment in North America
- 11.3. Demand and Supply Assessment in Europe
- 11.4. Demand and Supply Assessment in Asia-Pacific and Rest of the World
12. LIKELY PARTNER ANALYSIS
- 12.1. Chapter Overview
- 12.2. Methodology and Key Parameters
- 12.3. Likely Partner Analysis
- 12.3.1. Opportunities in North America
- 12.3.1.1. Most Likely Partners for Prefilled Syringe Fill / Finish Service Providers
- 12.3.1.2. Likely Partners for Prefilled Syringe Fill / Finish Service Providers
- 12.3.2. Opportunities in Europe
- 12.3.2.1. Most Likely Partners for Prefilled Syringe Fill / Finish Service Providers
- 12.3.2.2. Likely Partners for Prefilled Syringe Fill / Finish Service Providers
- 12.3.3. Opportunities in Asia-Pacific and Rest of the World
- 12.3.3.1. Most Likely Partners for Prefilled Syringe Fill / Finish Service Providers
- 12.3.3.2. Likely Partners for Prefilled Syringe Fill / Finish Service Providers
13. MARKET SIZING AND OPPORTUNITY ANALYSIS
- 13.1. Chapter Overview
- 13.2. Forecast Methodology and Key Assumptions
- 13.3. Overall Prefilled Syringe Fill / Finish Services Market, 2020-2030
- 13.3.1. Prefilled Syringe Fill / Finish Services Market: Distribution by Scale of Operation, 2020-2030
- 13.3.2. Prefilled Syringe Fill / Finish Services Market: Distribution by Geographical Location, 2020-2030
- 13.3.3. Prefilled Syringe Fill / Finish Services Market: Distribution by Type of Drug Molecule, 2020-2030
- 13.3.4. Prefilled Syringe Fill / Finish Services Market: Distribution by Therapeutic Area, 2020-2030
- 13.3.5. Prefilled Syringe Fill / Finish Services Market: Distribution by Syringe Barrel Material, 2020-2030
- 13.3.6. Prefilled Syringe Fill / Finish Services Market: Distribution by Number of Barrel Chambers, 2020-2030
14. FUTURE GROWTH OPPORTUNITIES
- 14.1. Chapter Overview
- 14.2. Growing Injectable Drugs Pipeline
- 14.3. Increase in Outsourcing of Fill / Finish Activities
- 14.4. Rising Preference for Self-Medication
- 14.5. Increase in Popularity of Prefilled Syringes
- 14.6. Advances in Aseptic Fill / Finish Technologies
15. PREFILLED SYRINGE MANUFACTURERS
- 15.1. Chapter Overview
- 15.2. Prefilled Syringes: List of Available / Under Development Devices
- 15.2.1. Analysis by Syringe Barrel Material
- 15.2.2. Analysis by Number of Barrel Chambers
- 15.2.3. Analysis by Type of Needle System
- 15.2.4. Analysis by Barrel Volume
- 15.3. Prefilled Syringes: List of Manufacturers
- 15.3.1. Analysis by Year of Establishment
- 15.3.2. Analysis by Company Size
- 15.3.3. Analysis by Location of Headquarters
16. CONCLUDING REMARKS
- 16.1. Chapter Overview
- 16.2. Key Takeaways
17. INTERVIEW TRANSCRIPTS
- 17.1. Chapter Overview
- 17.2. Intas Pharmaceuticals
- 17.2.1. Company Snapshot
- 17.2.2. Interview Transcript: Kirti Maheshwari, Chief Technical Officer
- 17.3. IDT Biologika
- 17.3.1. Company Snapshot
- 17.3.2. Interview Transcript: Gregor Kawaletz, Chief Commercial Officer
- 17.4. IDEO
- 17.4.1. Company Snapshot
- 17.4.2. Interview Transcript: Jesse Fourt, Design Director
- 17.5. Syngene
- 17.5.1. Company Snapshot
- 17.5.2. Interview Transcript: Purushottam Singnurkar, Research Director and Head of Formulation Development
- 17.6. Large CMO
- 17.6.1. Interview Transcript: Anonymous, Associate Director, Head of Process Sciences Formulation and Fill / Finish
18. APPENDIX 1: TABULATED DATA
19. APPENDIX 2: LIST OF COMPANIES
List Of Figures
- Figure 3.1 Steps Involved in the Manufacturing of Prefilled Syringes
- Figure 3.2 Steps Involved in Fill / Finish Operations of Prefilled Syringes
- Figure 3.3 Key Considerations for Selecting a CMO Partner
- Figure 3.4 Risks and Challenges Associated with Outsourcing Fill / Finish Operations
- Figure 4.1 Prefilled Syringe Fill / Finish Service Providers: Distribution by Year of Establishment
- Figure 4.2 Prefilled Syringe Fill / Finish Service Providers: Distribution by Company Size
- Figure 4.3 Prefilled Syringe Fill / Finish Service Providers: Distribution by Scale of Operation
- Figure 4.4 Prefilled Syringe Fill / Finish Service Providers: Distribution by Location of Headquarters
- Figure 4.5 Prefilled Syringe Fill / Finish Service Providers: Distribution by Location of Fill / Finish Facilities
- Figure 4.6 Prefilled Syringe Fill / Finish Service Providers: Distribution by Company Size and Type of Drug Molecule
- Figure 4.7 Prefilled Syringe Fill / Finish Service Providers: Distribution by Syringe Barrel Material
- Figure 4.8 Prefilled Syringe Fill / Finish Service Providers: Distribution by Syringe Fill Volume
- Figure 4.9 Prefilled Syringe Fill / Finish Service Providers: Distribution by Additional Services Offered
- Figure 4.10 Grid Representation: Distribution by Year of Establishment, Company Size and Type of Drug Molecule
- Figure 4.11 Logo Landscape: Distribution by Company Size and Type of Drug Molecule
- Figure 4.12 World Map Representation: Distribution by Scale of Operation and Location of Fill / Finish Facility
- Figure 8.1 Partnerships and Collaborations: Distribution by Year of Partnership, 2015-2019
- Figure 8.2 Partnerships and Collaborations: Distribution by Type of Partnership
- Figure 8.3 Partnerships and Collaborations: Distribution by Scale of Operation (Deal Specific)
- Figure 8.4 Partnerships and Collaborations: Distribution by Additional Services Offered (Deal Specific)
- Figure 8.5 Most Active Players: Distribution by Number of Partnerships
- Figure 8.6 Expansions: Distribution by Year of Expansion, 2015-2019
- Figure 8.7 Expansions: Distribution by Type of Expansion
- Figure 8.8 Expansions: Distribution by Expanded Scale of Operation
- Figure 8.9 Expansions: Distribution by Location of Expansion Project
- Figure 8.10 Expansions: Distribution by Type of Drug Molecule Involved
- Figure 8.11 Expansions: Distribution by Additional Services Offered (Expansion Specific)
- Figure 9.1 Global, Prefilled Syringe Fill / Finish Capacity: Distribution of Capacity by Size of Manufacturer (Sample Data Set)
- Figure 9.2 Global, Prefilled Syringe Fill / Finish Capacity: Distribution by Company Size of Manufacturer (in Million Units)
- Figure 9.3 Global, Prefilled Syringe Fill / Finish Capacity (by Number of Units): Distribution by Scale of Operation (in Million Units)
- Figure 9.4 Global, Prefilled Syringe Fill / Finish Capacity (by Number of Units): Distribution by Location of Headquarters (in Million Units)
- Figure 9.5 Global, Prefilled Syringe Fill / Finish Capacity (by Number of Units): Distribution by Location of Fill / Finish Facilities (in Million Units)
- Figure 9.6 Global, Prefilled Syringe Fill / Finish Capacity (by Number of Units): Distribution by Type of Drug Molecule (in Million Units)
- Figure 9.7 Global, Prefilled Syringe Fill / Finish Capacity: Distribution by Company Size of Manufacturer (in Million Liters)
- Figure 9.8 Global, Prefilled Syringe Fill / Finish Capacity (by Volume): Distribution by Scale of Operation (in Million Liters)
- Figure 9.9 Global, Prefilled Syringe Fill / Finish Capacity (by Volume): Distribution by Location of Headquarters (in Million Liters)
- Figure 9.10 Global, Prefilled Syringe Fill / Finish Capacity (by Volume): Distribution by Location of Fill / Finish Facilities (in Million Liters)
- Figure 9.11 Global, Prefilled Syringe Fill / Finish Capacity (by Volume): Distribution by Type of Drug Molecule (in Million Liters)
- Figure 10.1 Global, Demand for Prefilled Syringe Fill / Finish Services
- Figure 10.2 Global, Demand for Prefilled Syringe Fill / Finish Services: Distribution by Geography
- Figure 10.3 Global, Demand for Prefilled Syringe Fill / Finish Services: Distribution by Type of Drug Molecule
- Figure 10.4 Global, Demand for Prefilled Syringe Fill / Finish Services: Distribution by Therapeutic Area
- Figure 10.5 Global, Demand for Prefilled Syringe Fill / Finish Services: Distribution by Syringe Barrel Material
- Figure 10.6 Global, Demand for Prefilled Syringe Fill / Finish Services: Distribution by Number of Barrel Chambers
- Figure 10.7 Global, Prefilled Syringe Fill / Finish Services: Demand and Supply Dynamics
- Figure 11.1 Demand and Supply Assessment: North America
- Figure 11.2 Demand and Supply Assessment: Europe
- Figure 11.3 Demand and Supply Assessment: Asia-Pacific and Rest of the World
- Figure 12.1 Likely Partner Analysis: Distribution by Geography
- Figure 13.1. Overall Prefilled Syringe Fill / Finish Services Market, 2020-2030 (USD Billion)
- Figure 13.2. Prefilled Syringe Fill / Finish Services Market, 2020-2030: Distribution by Scale of Operation (USD Million)
- Figure 13.3. Prefilled Syringe Fill / Finish Services Market, 2020-2030: Distribution by Geographical Location (USD Million)
- Figure 13.4. Prefilled Syringe Fill / Finish Services Market, 2020-2030: Distribution by Type of Drug Molecule (USD Million)
- Figure 13.5. Prefilled Syringe Fill / Finish Services Market, 2020-2030: Distribution by Therapeutic Area (USD Million)
- Figure 13.6. Prefilled Syringe Fill / Finish Services Market, 2020-2030: Distribution by Syringe Barrel Material (USD Million)
- Figure 13.7. Prefilled Syringe Fill / Finish Services Market, 2020-2030: Distribution by Number of Barrel Chambers (USD Million)
- Figure 14.1. Growth Opportunities for Prefilled Syringe Fill / Finish Service Providers
- Figure 15.1 Prefilled Syringes: Distribution by Syringe Barrel Material
- Figure 15.2 Prefilled Syringes: Distribution by Number of Barrel Chambers
- Figure 15.3 Prefilled Syringes: Distribution by Type of Needle System
- Figure 15.4 Prefilled Syringes: Distribution by Barrel Volume
- Figure 15.5 Prefilled Syringe Manufacturers: Distribution by Year of Establishment
- Figure 15.6 Prefilled Syringe Manufacturers: Distribution by Company Size
- Figure 15.7 Prefilled Syringe Manufacturers: Distribution by Location of Headquarters
List Of Tables
- Table 3.1 Classification of Prefilled Syringes
- Table 4.1 Prefilled Syringe Fill / Finish Service Providers: List of Companies
- Table 4.2 Prefilled Syringe Fill / Finish Service Providers: Information on Location of Fill / Finish Facilities
- Table 4.3 Prefilled Syringe Fill / Finish Service Providers: Information on Type of Drug Molecule
- Table 4.4 Prefilled Syringe Fill / Finish Service Providers: Information on Syringe Barrel Material
- Table 4.5 Prefilled Syringe Fill / Finish Service Providers: Information on Syringe Fill Volume Range
- Table 4.6 Prefilled Syringe Fill / Finish Service Providers: Information on Additional Services Offered
- Table 4.6 Prefilled Syringe Fill / Finish Service Providers: Information on Fill / Finish Capability
- Table 5.1 Ajinomoto Bio-Pharma Services: Company Snapshot
- Table 5.2 Ajinomoto Bio-Pharma Services: Recent Developments and Future Outlook
- Table 5.3 AMRI: Company Snapshot
- Table 5.4 AMRI: Recent Developments and Future Outlook
- Table 5.5 BioPharma Solutions: Company Snapshot
- Table 5.6 BioPharma Solutions: Recent Developments and Future Outlook
- Table 5.7 Emergent BioSolutions: Company Snapshot
- Table 5.8 Emergent BioSolutions: Recent Developments and Future Outlook
- Table 5.9 Patheon: Company Snapshot
- Table 5.10 Patheon: Recent Developments and Future Outlook
- Table 5.11 PiSA Farmacéutica: Company Snapshot
- Table 5.12 PiSA Farmacéutica: Recent Developments and Future Outlook
- Table 6.1 Consort Medical: Company Snapshot
- Table 6.2 Consort Medical: Recent Developments and Future Outlook
- Table 6.3 EVER Pharma: Company Snapshot
- Table 6.4 EVER Pharma: Recent Developments and Future Outlook
- Table 6.5 GlaxoSmithKline: Company Snapshot
- Table 6.6 GlaxoSmithKline: Recent Developments and Future Outlook
- Table 6.7 IDT Biologika: Company Snapshot
- Table 6.8 IDT Biologika: Recent Developments and Future Outlook
- Table 6.9 Rentschler Biopharma: Company Snapshot
- Table 6.10 Rentschler Biopharma: Recent Developments and Future Outlook
- Table 6.11 Siegfried: Company Snapshot
- Table 6.12 Siegfried: Recent Developments and Future Outlook
- Table 6.13 Vetter Pharma: Company Snapshot
- Table 6.14 Vetter Pharma: Recent Developments and Future Outlook
- Table 7.1 Biocon: Company Snapshot
- Table 7.2 Biocon: Recent Developments and Future Outlook
- Table 7.3 Intas Pharmaceuticals: Company Snapshot
- Table 7.4 Intas Pharmaceuticals: Recent Developments and Future Outlook
- Table 7.5 Kemwell Biopharma: Company Snapshot
- Table 7.6 Kemwell Biopharma: Recent Developments and Future Outlook
- Table 7.7 Square Pharmaceuticals: Company Snapshot
- Table 7.8 Square Pharmaceuticals: Recent Developments and Future Outlook
- Table 7.9 USV: Company Snapshot
- Table 7.10 USV: Recent Developments and Future Outlook
- Table 8.1 Prefilled Syringe Fill / Finish Service Providers: Partnerships and Collaborations, 2015-2019
- Table 8.2 Prefilled Syringe Fill / Finish Service Providers: Recent Expansions, 2015-2019
- Table 9.1 Global Prefilled Syringe Fill / Finish Capacity (by Number of Units): Average Capacity by Company Size of Manufacturer (Sample Data Set)
- Table 12.1 Opportunities in North America: Most Likely Partners for Prefilled Syringe Fill / Finish Service Providers
- Table 12.2 Opportunities in North America: Likely Partners for Prefilled Syringe Fill / Finish Service Providers
- Table 12.3 Opportunities in Europe: Most Likely Partners for Prefilled Syringe Fill / Finish Service Providers
- Table 12.4 Opportunities in Europe: Likely Partners for Prefilled Syringe Fill / Finish Service Providers
- Table 12.5 Opportunities in Asia-Pacific and Rest of the World: Most Likely Partners for Prefilled Syringe Fill / Finish Service Providers
- Table 12.6 Opportunities in Asia-Pacific and Rest of the World: Likely Partners for Prefilled Syringe Fill / Finish Service Providers
- Table 15.1 Prefilled Syringes: List of Available / Under Development Devices
- Table 16.1 Prefilled Syringe Fill / Finish Services Market: Key Takeaways
- Table 17.1 Intas Pharmaceuticals: Key Highlights
- Table 17.2 IDT Biologika: Key Highlights
- Table 17.3 IDEO: Key Highlights
- Table 17.4 Syngene: Key Highlights
- Table 18.1 Prefilled Syringe Fill / Finish Service Providers: Distribution by Year of Establishment
- Table 18.2 Prefilled Syringe Fill / Finish Service Providers: Distribution by Company Size
- Table 18.3 Prefilled Syringe Fill / Finish Service Providers: Distribution by Scale of Operation
- Table 18.4 Prefilled Syringe Fill / Finish Service Providers: Distribution by Location of Headquarters
- Table 18.5 Prefilled Syringe Fill / Finish Service Providers: Distribution by Location of Fill / Finish Facilities
- Table 18.6 Prefilled Syringe Fill / Finish Service Providers: Distribution by Company Size and Type of Drug Molecule
- Table 18.7 Prefilled Syringe Fill / Finish Service Providers: Distribution by Syringe Barrel Material
- Table 18.8 Prefilled Syringe Fill / Finish Service Providers: Distribution by Syringe Fill Volume
- Table 18.9 Prefilled Syringe Fill / Finish Service Providers: Distribution by Additional Services Offered
- Table 18.10 Partnerships and Collaborations: Distribution by Year of Partnership, 2015-2019
- Table 18.11 Partnerships and Collaborations: Distribution by Type of Partnership
- Table 18.12 Partnerships and Collaborations: Distribution by Scale of Operation (Deal Specific)
- Table 18.13 Partnerships and Collaborations: Distribution by Additional Services Offered (Deal Specific)
- Table 18.14 Most Active Players: Distribution by Number of Partnerships
- Table 18.15 Expansions: Distribution by Year of Expansion, 2015-2019
- Table 18.16 Expansions: Distribution by Type of Expansion
- Table 18.17 Expansions: Distribution by Expanded Scale of Operation
- Table 18.18 Expansions: Distribution by Location of Expansion Project
- Table 18.19 Expansions: Distribution by Type of Drug Molecule Involved
- Table 18.20 Expansions: Distribution by Additional Services Offered (Expansion Specific)
- Table 18.21 Global, Prefilled Syringe Fill / Finish Capacity: Distribution of Capacity by Size of Manufacturer (Sample Data Set)
- Table 18.22 Global, Prefilled Syringe Fill / Finish Capacity: Distribution by Company Size of Manufacturer (in Million Units)
- Table 18.23 Global, Prefilled Syringe Fill / Finish Capacity (by Number of Units): Distribution by Scale of Operation (in Million Units)
- Table 18.24 Global, Prefilled Syringe Fill / Finish Capacity (by Number of Units): Distribution by Location of Headquarters (in Million Units)
- Table 18.25 Global, Prefilled Syringe Fill / Finish Capacity (by Number of Units): Distribution by Location of Fill / Finish Facilities (in Million Units)
- Table 18.26 Global, Prefilled Syringe Fill / Finish Capacity (by Number of Units): Distribution by Type of Drug Molecule (in Million Units)
- Table 18.27 Global, Prefilled Syringe Fill / Finish Capacity: Distribution by Company Size of Manufacturer (in Million Liters)
- Table 18.28 Global, Prefilled Syringe Fill / Finish Capacity (by Volume): Distribution by Scale of Operation (in Million Liters)
- Table 18.29 Global, Prefilled Syringe Fill / Finish Capacity (by Volume): Distribution by Location of Headquarters (in Million Liters)
- Table 18.30 Global, Prefilled Syringe Fill / Finish Capacity (by Volume): Distribution by Location of Fill / Finish Facilities (in Million Liters)
- Table 18.31 Global, Prefilled Syringe Fill / Finish Capacity (by Volume): Distribution by Type of Drug Molecule (in Million Liters)
- Table 18.32 Global, Demand for Prefilled Syringe Fill / Finish Services
- Table 18.33 Global, Demand for Prefilled Syringe Fill / Finish Services: Distribution by Geography
- Table 18.34 Global, Demand for Prefilled Syringe Fill / Finish Services: Distribution by Type of Drug Molecule
- Table 18.35 Global, Demand for Prefilled Syringe Fill / Finish Services: Distribution by Therapeutic Area
- Table 18.36 Global, Demand for Prefilled Syringe Fill / Finish Services: Distribution by Syringe Barrel Material
- Table 18.37 Global, Demand for Prefilled Syringe Fill / Finish Services: Distribution by Number of Barrel Chambers
- Table 18.38 Demand and Supply Assessment: North America
- Table 18.39 Demand and Supply Assessment: Europe
- Table 18.40 Demand and Supply Assessment: Asia-Pacific and Rest of the World
- Table 18.41 Likely Partner Analysis: Distribution by Geography
- Table 18.42 Overall Prefilled Syringe Fill / Finish Services Market, Conservative, Base and Optimistic Scenarios, 2020-2030 (USD Billion)
- Table 18.43 Prefilled Syringe Fill / Finish Services Market, 2020-2030: Distribution by Scale of Operation, Conservative, Base and Optimistic Scenarios, (USD Million)
- Table 18.44 Prefilled Syringe Fill / Finish Services Market, 2020-2030: Distribution by Geographical Location, Conservative, Base and Optimistic Scenarios, (USD Million)
- Table 18.45 Prefilled Syringe Fill / Finish Services Market, 2020-2030: Distribution by Type of Drug Molecule, Conservative, Base and Optimistic Scenarios, (USD Million)
- Table 18.46 Prefilled Syringe Fill / Finish Services Market, 2020-2030: Distribution by Therapeutic Area, Conservative, Base and Optimistic Scenarios, (USD Million)
- Table 18.47 Prefilled Syringe Fill / Finish Services Market, 2020-2030: Distribution by Syringe Barrel Material, Conservative, Base and Optimistic Scenarios, (USD Million)
- Table 18.48 Prefilled Syringe Fill / Finish Services Market, 2020-2030: Distribution by Number of Barrel Chambers, Conservative, Base and Optimistic Scenarios, (USD Million)
- Table 18.49 Prefilled Syringes: Distribution by Syringe Barrel Material
- Table 18.50 Prefilled Syringes: Distribution by Number of Barrel Chambers
- Table 18.51 Prefilled Syringes: Distribution by Type of Needle System
- Table 18.52 Prefilled Syringes: Distribution by Barrel Volume
- Table 18.53 Prefilled Syringe Manufacturers: Distribution by Year of Establishment
- Table 18.54 Prefilled Syringe Manufacturers: Distribution by Company Size
- Table 18.55 Prefilled Syringe Manufacturers: Distribution by Location of Headquarters
Listed Companies
The following companies and organizations have been mentioned in the report.
- 1. AbbVie Contract Manufacturing
- 2. Aguettant
- 3. AJ Biologics
- 4. Ajinomoto Bio-Pharma Services
- 5. Akron Biotech
- 6. Akums Drugs and Pharmaceuticals
- 7. Alanza
- 8. Alcami
- 9. Alfasigma
- 10. Alkermes
- 11. AMRI
- 12. APL
- 13. Aristopharma
- 14. Austrianova
- 15. Automated Systems of Tacoma
- 16. Axcellerate Pharma
- 17. Bahrain Pharma
- 18. Baxter
- 19. Becton Dickinson
- 20. Berkshire Sterile Manufacturing
- 21. Beximco Pharma
- 22. Bio Elpida
- 23. Biocon
- 24. BioConnection
- 25. Biomedical Advanced Research and Development Authority
- 26. BioPharma Solutions
- 27. Biotech Vision Care
- 28. BirgiMefar
- 29. Boehringer Ingelheim BioXcellence
- 30. Bryllan
- 31. CARBOGEN AMCIS
- 32. Catalent Biologics
- 33. Cenexi
- 34. Cerium Pharmaceuticals
- 35. CinnaGen
- 36. Ciron Drugs and Pharmaceutical
- 37. Cobra Biologics
- 38. Consort Medical
- 39. Cook Pharmica
- 40. CordenPharma
- 41. Dalton Pharma Services
- 42. Delpharm
- 43. Dhruv Life sciences
- 44. DM Bio
- 45. EirGen Pharma
- 46. Emcure Pharmaceuticals
- 47. Emergent BioSolutions
- 48. Eurofins BioPharma
- 49. European Medical Contract Manufacturing
- 50. EVER Pharma
- 51. ExCellThera
- 52. FACET
- 53. Fresenius Kabi Contract Manufacturing
- 54. Gadea Pharmaceutical Group
- 55. Genovior Biotech
- 56. Gerresheimer
- 57. Gland Pharma
- 58. GP Pharm
- 59. Grand River Aseptic Manufacturing
- 60. GlaxoSmithKline
- 61. Gulf Biotech
- 62. Health Biotech
- 63. Healthcare Pharmaceuticals
- 64. Hetero Drugs
- 65. Hisun Pharmaceuticals USA
- 66. IDEO
- 67. IDT Biologika
- 68. Injectalia
- 69. Intas Pharmaceuticals
- 70. Integrity Bio
- 71. Irisys
- 72. Italfarmaco
- 73. Kemwell Biopharma
- 74. Kilitch Healthcare
- 75. KP Pharmaceutical Technology
- 76. Lifecore Biomedical
- 77. LSNE Contract Manufacturing
- 78. Lubrizol Life Science Health
- 79. Medefil
- 80. Mithra
- 81. Mitsubishi Gas Chemical
- 82. Mycenax Biotech
- 83. Nipro
- 84. Northway Biotechpharma
- 85. Nova Laboratories
- 86. Ology Bioservices
- 87. OmniChem
- 88. Ompi
- 89. Oncotec Pharma Produktion
- 90. Patheon
- 91. PCI Pharma Services
- 92. Pfizer CentreOne
- 93. Pfizer Injectables
- 94. Pharmaceutics International
- 95. Pierre Fabre
- 96. PiSA Farmacéutica
- 97. Polpharma Biologics
- 98. Praxis Pharmaceutical
- 99. Precision Ocular Metrology
- 100. PrimaPharma
- 101. PYRAMID Laboratories
- 102. Reliance Life Sciences
- 103. Rentschler Biopharma
- 104. Rompharm
- 105. Rovi CM
- 106. Samsung Bioepis
- 107. Samsung Biologics
- 108. Sandoz
- 109. Saudi Biotech Manufacturing
- 110. Schott
- 111. Schott Kaisha
- 112. ScinoPharm
- 113. Selecta Biosciences
- 114. Sewa Medicals
- 115. Shandong Pharmaceutical Glass
- 116. Shandong Weigao
- 117. Sharp Corporation
- 118. SHL Group
- 119. Siegfried
- 120. Singota Solutions
- 121. Sovereign Pharma
- 122. Square Pharmaceuticals
- 123. Sunshine Health Products
- 124. Swissfillon
- 125. Symphogen
- 126. Syngene
- 127. Taisei Kako
- 128. Taiyo Yakuhin
- 129. Tanvex BioPharma
- 130. Terumo
- 131. Tolmar
- 132. TriPharm Services
- 133. Unicep
- 134. United States Army Medical Materiel Development Activity
- 135. USV
- 136. Vanrx Pharmasystems
- 137. VELIT Biopharmaceuticals
- 138. Vetter Pharma
- 139. VxP Biologics
- 140. West Pharmaceuticals
- 141. Wockhardt
- 142. Zen Pharma